1. Home
  2. INTS vs STI Comparison

INTS vs STI Comparison

Compare INTS & STI Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • INTS
  • STI
  • Stock Information
  • Founded
  • INTS 2012
  • STI 2014
  • Country
  • INTS United States
  • STI United States
  • Employees
  • INTS N/A
  • STI N/A
  • Industry
  • INTS Biotechnology: Pharmaceutical Preparations
  • STI
  • Sector
  • INTS Health Care
  • STI
  • Exchange
  • INTS Nasdaq
  • STI NYSE
  • Market Cap
  • INTS 8.4M
  • STI 9.5M
  • IPO Year
  • INTS 2023
  • STI N/A
  • Fundamental
  • Price
  • INTS $0.28
  • STI $3.93
  • Analyst Decision
  • INTS Strong Buy
  • STI
  • Analyst Count
  • INTS 2
  • STI 0
  • Target Price
  • INTS $6.75
  • STI N/A
  • AVG Volume (30 Days)
  • INTS 5.7M
  • STI 50.6K
  • Earning Date
  • INTS 08-11-2025
  • STI 08-12-2025
  • Dividend Yield
  • INTS N/A
  • STI N/A
  • EPS Growth
  • INTS N/A
  • STI N/A
  • EPS
  • INTS N/A
  • STI 6.72
  • Revenue
  • INTS N/A
  • STI N/A
  • Revenue This Year
  • INTS N/A
  • STI N/A
  • Revenue Next Year
  • INTS N/A
  • STI N/A
  • P/E Ratio
  • INTS N/A
  • STI $0.59
  • Revenue Growth
  • INTS N/A
  • STI N/A
  • 52 Week Low
  • INTS $0.26
  • STI $2.94
  • 52 Week High
  • INTS $4.94
  • STI $55.00
  • Technical
  • Relative Strength Index (RSI)
  • INTS 35.87
  • STI 44.04
  • Support Level
  • INTS $0.32
  • STI $3.78
  • Resistance Level
  • INTS $0.36
  • STI $5.59
  • Average True Range (ATR)
  • INTS 0.03
  • STI 0.43
  • MACD
  • INTS 0.00
  • STI -0.12
  • Stochastic Oscillator
  • INTS 1.88
  • STI 8.27

About INTS Intensity Therapeutics Inc. Common stock

Intensity Therapeutics Inc is a clinical-stage biotechnology company pioneering a new immune-based approach to treat solid tumor cancers. The company leverages its DfuseRxtechnology platform to create new, proprietary drug formulations that, following direct injection, rapidly disperse throughout a tumor and diffuse therapeutic agents into cancer cells. Intensity's product candidates have the potential to induce an adaptive systemic immune response that not only attacks the injected tumor, but also non-injected tumors. Their pipeline is focused on realizing the full potential of INT230-6 in metastatic and local disease settings to help cancer patients with unmet medical need.

About STI SOLIDION TECHNOLOGY INC

Solidion Technology Inc is engaged in researching, developing and manufacturing battery materials and components, as well as the development and production of next-generation batteries for energy storage systems and electric vehicles for ground, air, and sea transportation. It is recognized as a IP leader in both the high-capacity anode and the high-energy solid-state battery.

Share on Social Networks: